See more : Nu Ride Inc. (NRDE) Income Statement Analysis – Financial Results
Complete financial analysis of NEXGEL, Inc. (NXGL) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NEXGEL, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Solaris Resources Inc. (SLS.TO) Income Statement Analysis – Financial Results
- Yankuang Energy Group Company Limited (YZCHF) Income Statement Analysis – Financial Results
- Ancom Nylex Berhad (4758.KL) Income Statement Analysis – Financial Results
- Evergreen Marine Corporation (Taiwan) Ltd. (2603.TW) Income Statement Analysis – Financial Results
- Canoo Inc. (GOEV) Income Statement Analysis – Financial Results
NEXGEL, Inc. (NXGL)
About NEXGEL, Inc.
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.09M | 2.05M | 1.55M | 674.00K | 717.00K | 2.21M | 1.99M | 2.15M |
| Cost of Revenue | 3.47M | 1.79M | 1.54M | 965.00K | 854.00K | 1.70M | 1.85M | 2.27M |
| Gross Profit | 619.00K | 256.00K | 9.00K | -291.00K | -137.00K | 514.00K | 147.00K | -114.00K |
| Gross Profit Ratio | 15.14% | 12.50% | 0.58% | -43.18% | -19.11% | 23.23% | 7.38% | -5.30% |
| Research & Development | 103.00K | 367.00K | 31.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.02M | 2.38M | 2.54M | 1.96M | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 620.00K | 436.00K | 320.00K | 13.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.99M | 3.24M | 2.54M | 1.97M | 1.79M | 2.40M | 1.12M | 1.75M |
| Other Expenses | 0.00 | 3.00K | 13.00K | 8.00K | 0.00 | 0.00 | 0.00 | 25.00K |
| Operating Expenses | 4.10M | 3.60M | 2.58M | 1.97M | 1.79M | 2.40M | 1.12M | 1.75M |
| Cost & Expenses | 7.57M | 5.40M | 4.12M | 2.93M | 2.64M | 4.10M | 2.96M | 4.02M |
| Interest Income | 0.00 | 1.34M | 2.00M | 10.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 15.00K | 1.34M | 2.00M | 10.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 443.00K | 301.00K | 113.00K | 50.00K | 67.00K | 322.00K | 316.00K | 324.00K |
| EBITDA | -2.73M | -3.11M | -2.20M | -2.20M | -1.86M | -1.57M | -653.00K | -1.54M |
| EBITDA Ratio | -66.76% | -148.63% | -158.41% | -326.71% | -259.00% | -70.76% | -32.78% | -71.56% |
| Operating Income | -3.48M | -3.35M | -2.57M | -2.26M | -1.92M | -1.89M | -969.00K | -1.86M |
| Operating Income Ratio | -85.03% | -163.48% | -165.70% | -335.31% | -268.34% | -85.31% | -48.64% | -86.62% |
| Total Other Income/Expenses | 289.00K | -1.40M | -1.74M | -4.00K | 1.00K | 0.00 | 0.00 | 25.00K |
| Income Before Tax | -3.19M | -4.75M | -4.31M | -2.26M | -1.92M | -1.89M | -969.00K | -1.84M |
| Income Before Tax Ratio | -77.97% | -231.74% | -277.89% | -335.91% | -268.20% | -85.31% | -48.64% | -85.46% |
| Income Tax Expense | 0.00 | 1.40M | 2.00M | 18.00K | -104.86K | 160.86K | -16.00K | -63.00K |
| Net Income | -3.16M | -6.14M | -6.31M | -2.28M | -1.92M | -1.89M | -953.00K | -1.78M |
| Net Income Ratio | -77.21% | -300.00% | -406.71% | -338.58% | -268.20% | -85.31% | -47.84% | -82.53% |
| EPS | -0.56 | -1.10 | -1.13 | -0.02 | -0.14 | -0.34 | -0.17 | -0.32 |
| EPS Diluted | -0.56 | -1.10 | -1.13 | -0.02 | -0.14 | -0.34 | -0.17 | -0.32 |
| Weighted Avg Shares Out | 5.67M | 5.57M | 5.57M | 104.28M | 13.57M | 5.57M | 5.57M | 5.57M |
| Weighted Avg Shares Out (Dil) | 5.67M | 5.57M | 5.57M | 104.28M | 13.57M | 5.57M | 5.57M | 5.57M |
NEXGEL reports impressive revenue growth in 1Q, expects $1M revenue in 2Q
NEXGEL (NASDAQ:NXGL), a leading provider of hydrogel products, reported a 56.6% year-over-year increase in revenue over the first quarter of 2023. Total revenue for the three-month period to end March 31 came in at $620,000 driven by sales growth in...
NEXGEL to Report First Quarter 2023 Financial Results on May 15th
Management will host a conference call at 4:30 P . M . ET on the same day
NEXGEL sees FY22 revenue surge 32% on rise in contract manufacturing and branded consumer products
NEXGEL (NASDAQ:NXGL) Inc has announced that it fiscal 2022 revenue rose 32% year over year to $2.05 million, which the company attributed primarily to an increase in contract manufacturing and branded consumer products. The provider of ultra-gentle, high-water-content hydrogels also...
NEXGEL teams up with former lacrosse pro Greg 'The Beast' Gurenlian to bring Turfguard patches to players
NEXGEL (NASDAQ:NXGL) Inc has announced a partnership with former Major League Lacrosse (MLL) player and founder of The Face-off Academy, Greg “The Beast” Gurenlian, to provide athletes with Turfguard, the company's unique hydrogel dressing. NEXGEL (NASDAQ:NXGL)'s Turfguard is a patch designed...
NEXGEL strikes partnership with CG Labs to seize strategic opportunities
NEXGEL (NASDAQ:NXGL) has dealt into in a new joint venture with CG Laboratories Inc, one of its largest customers, in a converting and packaging business. The producer of high-water-content hydrogel products has had a business relationship with CG Labs, a medical...
NEXGEL announces appointment of Scott Henry, managing director at ROTH Capital Partners, as a new independent director to its board
NEXGEL Inc (NASDAQ:NXGL) has announced the appointment of Scott Henry as a new independent director to the company's board effective immediately, he will also serve as a member of the board's Audit Committee. Henry is a managing director and senior...
NEXGEL launches new hydrogel dressing to treat turf burns and protect athletic wounds
NEXGEL (NASDAQ:NXGL) Inc said it has launched a unique hydrogel dressing, called Turfguard, for treating painful turf burns and protecting sports-related wounds. “For athletes, turf burns and skin abrasions are often a common, unfortunate part of the game,” said Adam...
NEXGEL says Q3 revenue jumps almost 70%
NEXGEL (NASDAQ:NXGL), the leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, has announced its results for the third quarter to September 30, 2022, which revealed strong revenue growth and an improvement in the gross margin. Revenue...
NEXGEL studies diclofenac hydrogel patches as new pain medication delivery method
NEXGEL (NASDAQ:NXGL) has announced positive results from its proof-of-concept study on idiclofenac hydrogel patches designed to treat pain caused by arthritis, joint pain, muscle aches and more. The Langhorne, Pennsylvania-based company said the study compared its diclofenac hydrogel patches with the...
NEXGEL develops hydrogel patch to treat lazy eye; works better for younger children
NEXGEL (NASDAQ:NXGL) said it has developed a new hydrogel eye patch to treat amblyopia, a type of poor vision that typically occurs in one eye but can occur in both. The condition is also called lazy eye.
Source: https://incomestatements.info
Category: Stock Reports